Differences in Spending for Diabetes and Multiple Chronic Conditions in Michigan Medicare Beneficiaries

被引:2
|
作者
Clements, John M. [1 ,2 ]
Ragina, Neli P. [1 ]
Killingsworth, Jordan [1 ]
Weiss, Thomas G. [1 ]
Husain, S. Akbar [1 ]
Rain, Mariam Zunnu [1 ]
Clark, Kellie M. [1 ]
Alla, Spandana [1 ]
Jin, Michelle G. [1 ]
机构
[1] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA
[2] Michigan State Univ, Coll Human Med, 130 E 2nd St, Flint, MI 48502 USA
来源
AMERICAN JOURNAL OF MANAGED CARE | 2020年 / 26卷 / 11期
基金
美国国家卫生研究院;
关键词
RACIAL/ETHNIC DISPARITIES; CARE; HEALTH; COSTS; MELLITUS; OUTCOMES;
D O I
10.37765/ajmc.2020.88531
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
OBJECTIVES: To determine which combinations of type 2 diabetes (T2D) and multiple chronic conditions (MCC) contribute to total spending and differences in spending between groups based on sex, race/ethnicity, and rural residency. STUDY DESIGN: Retrospective cohort study using 2012 Medicare claims data from beneficiaries in Michigan with T2D. METHODS: Zero-inflated Poisson regression models to estimate relationships of demographic characteristics and MCC combinations on hospital outpatient, acute inpatient, skilled nursing, hospice, and Part D drug spending. RESULTS: Across most MCC combinations, there are lower odds of no spending, with a concurrent increase in the expected mean of actual spending when payments are made, except for hospital outpatient costs. For hospital outpatient services, we observed lower spending across all MCC combinations. When controlling for MCC, we generally found that compared with White beneficiaries, Black, Asian/Pacific Islander, and Hispanic beneficiaries experience increased odds of no spending, but when payments were made, payments generally increased. American Indian/Alaska Native beneficiaries are the exception; they experience decreased odds of no payments for hospital outpatient and acute inpatient services, with a concurrent decrease in mea expected payments. CONCLUSIONS: When considering a range of MCC combinations, we observed differences in total payments between racial/ethnic minority groups and White beneficiaries. Our results highlight the ongoing need to make changes in the health care system to make the system more accessible to racial/ethnic minority groups.
引用
收藏
页码:E362 / +
页数:12
相关论文
共 50 条
  • [31] Use and Spending on Antineoplastic Therapy for Medicare Beneficiaries With Cancer
    Davidoff, Amy J.
    Shaffer, Thomas
    Erten, Mujde Z.
    Shoemaker, J. Samantha
    Zuckerman, Ilene H.
    Pandya, Naimish
    Stuart, Bruce C.
    Bryant-Comstock, Lynda G.
    Shenolikar, Rahul
    MEDICAL CARE, 2013, 51 (04) : 351 - 360
  • [32] Health Professional Shortage Areas and Acute Care Utilization Among Medicare Beneficiaries with Multiple Chronic Conditions
    McMenamin, Amy
    Turi, Eleanor
    Dixon, Justinna
    Liu, Jianfang
    Martsolf, Grant
    Poghosyan, Lusine
    NURSING RESEARCH, 2024, 73 (03) : E151 - E151
  • [33] The Effect of Obesity and Chronic Conditions on Medicare Spending, 1987–2011
    Lindsay Allen
    Ken Thorpe
    Peter Joski
    PharmacoEconomics, 2015, 33 : 691 - 697
  • [34] Population Characteristics and Spending Patterns of High-Expenditure Patients among Medicare Beneficiaries with Diabetes
    Wang, Yu
    Zhang, Ping
    DIABETES, 2022, 71
  • [35] County-Level Concentration of Selected Chronic Conditions Among Medicare Fee-for-Service Beneficiaries and Its Association with Medicare Spending in the United States, 2017
    Matthews, Kevin A.
    Gaglioti, Anne H.
    Holt, James B.
    McGuire, Lisa C.
    Greenlund, Kurt J.
    POPULATION HEALTH MANAGEMENT, 2021, 24 (02) : 214 - 221
  • [36] Diabetes Prevention And Medicare Spending
    Kuller, Lewis H.
    HEALTH AFFAIRS, 2017, 36 (07)
  • [37] Lipid testing in Medicare beneficiaries with diabetes and chronic kidney disease.
    Gilbertson, DT
    Li, SL
    Collins, AJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 442A - 442A
  • [38] Spending, utilization, and coverage for chronic rhinosinusitis with nasal polyposis therapies among Medicare Advantage beneficiaries
    Bhat, Akash M.
    Soler, Zachary M.
    Rathi, Vinay K.
    Schlosser, Rodney J.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2024, 14 (10) : 1643 - 1646
  • [39] The rise in spending among Medicare beneficiaries: The role of chronic disease prevalence and changes in treatment intensity
    Thorpe, Kenneth E.
    Howard, David H.
    HEALTH AFFAIRS, 2006, 25 (05) : W378 - W388
  • [40] Medicare Advantage Disenrollment Among Beneficiaries With Chronic Conditions-Reply
    Raver, Eli
    Jung, Jeah
    Xu, Wendy Y.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (22): : 2216 - 2216